Indication
Neonatal Death
8 clinical trials
10 products
1 drug
Clinical trial
Calcium Aspirin Multiple Micronutrients (CAMMS) or Iron-folic Acid (IFA) to Reduce Preterm BirthStatus: Withdrawn, Estimated PCD: 2026-06-30
Product
Calcium AspirinProduct
AmpicillinProduct
GentamycinProduct
Normal salineClinical trial
Vitality in Infants Via Azithromycin for Neonates TrialStatus: Not yet recruiting, Estimated PCD: 2027-07-31
Product
AzithromycinClinical trial
Randomized Trial Evaluating the Non-specific Effects of BCG-Bulgaria and BCG-Denmark in Guinea-Bissau: Effects on Mortality, Morbidity, and BCG Skin ReactionsStatus: Recruiting, Estimated PCD: 2024-07-01
Product
BCG-DenmarkProduct
BCG-BulgariaClinical trial
Less Invasive Surfactant Administration in NigeriaStatus: Recruiting, Estimated PCD: 2024-06-30
Product
SurfactantClinical trial
The Neuroprotective Impact of Magnesium Sulphate Therapy for Preterm Deliveries. Loading Dose Alone Strategy Versus Loading Plus Maintenance Dose Strategy.Status: Recruiting, Estimated PCD: 2024-06-30
Product
Magnesium sulfateClinical trial
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS: A Single-dose, Double-blind, Random Allocation, Sham-control, Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Product
Infasurf AeroClinical trial
Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2022-10-07
Drug
Varlilumab